Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike - Wang, Qian; Guo, Yicheng; Liu, Liyuan; Schwanz, Logan T.; Li, Zhiteng; Nair, Manoj S.; Ho, Jerren; Zhang, Richard M.; Iketani, Sho; Yu, Jian; Huang, Yiming; Qu, Yiming; et al. (Nature (London), 2023)
Keywords: 101/1; 13/1; 13/109; 38/70; 631/250/2161; 631/250/255/2514; 631/326/596/2553; 631/326/596/2554; 631/326/596/2558; 82/1; 82/103; 82/80; 82/83; Affinity; Antibodies; Antibodies, Monoclonal - immunology; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Antigenicity; Coronaviruses; COVID-19; COVID-19 - immunology; COVID-19 - virology; COVID-19 Vaccines - immunology; Epitopes; Epitopes, B-Lymphocyte - immunology; Humanities and Social Sciences; Humans; Immune Sera - immunology; Immunization; Immunogenicity, Vaccine; Monoclonal antibodies; multidisciplinary; Mutation; Receptors; Receptors, Virus - metabolism; SARS-CoV-2 - classification; SARS-CoV-2 - genetics; SARS-CoV-2 - immunology; SARS-CoV-2 - metabolism; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; Spike Glycoprotein, Coronavirus - metabolism; Spike protein; Vaccines; Viral diseases; Viruses